3625 results for «2515»

Filter By

3625 results

Lifetime management of patients with aortic stenosis

06 Oct 2022 – From AICT-AsiaPCR 2022

In this AICT-AsiaPCR 2022 session, review a ViV case to consider coronary occlusion and CT analysis, and examine a TAVI case to discuss failed TAVI bioprosthesis, so as to develop strategies for patients with AS and long-life expectancy.

Lifetime management of patients with aortic stenosis

Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials

07 Oct 2022 – From AICT-AsiaPCR 2022

Take advantage of this AICT-AsiaPCR 2022 session to learn in detail about the FAME 3 and MASTER-DAPT trials and how to use their results in daily practice, and to better understand what is behind the term "non-inferiority" and when and how to choose a non-inferiority margin.

Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials

Rotational atherectomy for the treatment of calcified coronary lesion - Session with LIVE case

07 Oct 2022 – From AICT-AsiaPCR 2022

Let's see how this 80-year-old female patient with hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, history of ischaemic heart disease (2018) and NSTEMI (August 2022), currently asymptomatic but mainly homebound, was treated LIVE, and learn more about the treatment of calcified coronary lesion.

Rotational atherectomy for the treatment of calcified coronary lesion

DCB in variable day-to-day clinical scenarios

07 Oct 2022 – From AICT-AsiaPCR 2022

In this AICT AsiaPCR 2022 session 4 cases will be discussed that will enable you to learn more about drug-coated balloons and the variable indications for their use in daily practice, or techniques for using them in different lesion settings.

DCB in variable day-to-day clinical scenarios

Treatment of calcified lesions

07 Oct 2022 – From AICT-AsiaPCR 2022

Consider a 66-year-old man, hypertensive and diabetic for 10 years, with history of recurrent substernal chest pain and exertional dyspnea, who presented with easy fatigability and shortness of breath, or a 72-year-old man on dialysis who presented with STEMI and severe calcified stenosis of LAD/DI bifurcation,...

Treatment of calcified lesions

AICT-AsiaPCR 2022 Opening Ceremony

06 Oct 2022 – From AICT-AsiaPCR 2022

After two years without being able to meet, the joy of opening this 2022 session of the AICT-AsiaPCR Congress is palpable in this video broadcasting the opening ceremony. After a quick retrospective of the previous editions, the presenters unveil the objectives of this 2022 version and...

AICT-AsiaPCR 2022 Opening Ceremony

Beyond the guidelines of STEMI management: challenges in Southeast Asia

06 Oct 2022 – From AICT-AsiaPCR 2022

In this session, observe several challenging STEMI cases, such as a 48-year-old non-smoking Thai man with gout admitted for chest pain, or a 68-year-old woman with a history of HT, DM2, and PAD who presented with an anterior lateral STEMI and was indicated for PPCI, and...

Beyond the guidelines of STEMI management: challenges in Southeast Asia

Rapid-fire abstracts: session 1

27 Nov 2022 – From PCR London Valves 2022

Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!

Rapid-fire abstracts: session 1

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

21 Nov 2021 – From PCR London Valves

Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

Transcatheter mitral valve replacement: patient selection and hemodynamic stability

22 Nov 2021 – From PCR London Valves

Watch this session broadcast at PCR London Valves 2021 to find out more about TMVR as a novel treatment option for patients with mitral disease, to learn how to identify the right candidate for TMVR, and to understand how to best medically manage patients peri-procedurally.

Transcatheter mitral valve replacement: patient selection and hemodynamic stability

Obtaining commissural alignment in TAVI

23 Nov 2021 – From PCR London Valves 2021

Watch this session from PCR London Valves 2021 about the importance of commissural alignment in TAVI to know how to achieve commissural alignment with different TAVI systems, and to discover a step-by-step demonstration of patient-specific commissural alignment with the ACURATE neo2 THV system.

Obtaining commissural

Lifetime management of patients with severe aortic stenosis

22 Nov 2021 – From PCR London Valves

Don't miss this PCR London Valves 2021 session if you wish to discuss the importance of lifetime management in patients with severe aortic stenosis, to learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry, and to understand how valve design, implant technique, embolic...

Lifetime management of patients with severe aortic stenosis

Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis

21 Nov 2021 – From PCR London Valves 2021

Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.

Predictability at release

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

23 Nov 2021 – From PCR London Valves

Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

EAPCI: patient initiatives around the world

22 Nov 2021 – From PCR London Valves 2021

In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.

EAPCI:  patient initiatives around the world

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options

21 Nov 2021 – From PCR London Valves 2021

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...

From TAVI to mitral and

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure

21 Nov 2021 – From PCR London Valves

In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...

From TAVI to mitral and tricuspid - Part 1 - Best long-term outcomes start with the first procedure

From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options

22 Nov 2021 – From PCR London Valves

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...

From TAVI to mitral and tricupid - Part 2 - Securing long-term patient options

Innovation and imaging guidance for tricuspid valve replacement

21 Nov 2021 – From PCR London Valves

Watch this TNT session broadcast at PCR London Valves 2021 Congress to learn more about the crucial importance of understanding imaging and having high-quality imaging to guide transcatheter tricuspid valve intervention.

Innovation and imaging guidance for tricuspid valve replacement

HighLife TSMVR study status and new developments

22 Nov 2021 – From PCR London Valves 2021

Watch this session from the PCR London Valves 2021 Congress to find out more about HighLife systems and how it works, to witness a live recorded case presentation, to get clinical data, and to get an idea of the upcoming future alterations of the device to...

HighLife TSMVR study status and new developments
Didn’t find what you were looking for?